Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$49.26 - $74.5 $73,890 - $111,750
-1,500 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$56.91 - $127.53 $85,365 - $191,295
1,500 New
1,500 $165,000

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $617M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Lumina Fund Management LLC Portfolio

Follow Lumina Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lumina Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lumina Fund Management LLC with notifications on news.